During the year 2012, the bioscience industry in the Asia Pacific region clocked $154.40 billion in revenues, recording a double-digit growth of 11.07 percent over $139 billion of 2011. Around 45 percent of this growth came from China and almost 30 percent from India.

The Top 20 companies in Asia contributed over 60 percent of the publicly listed companies' revenue of $86.87 billion. And the fastest growing 50 companies contributed $31 billion to the overall revenue. The list of Asia's Top 20 publicly listed bioscience companies by revenue for the year 2012 is below:

Asia's Top 20 Publicly Listed Bioscience Companies by Revenue (2012)
Rank	Company	Country	Revenue CY 2012	Revenue CY 2011	Revenue CY 2010	Revenue CY 2009	Revenue CY 2008	% Growth over 2011
1	Sinopharm	China	21728.89	16355.97	10226.54	6884.09	5588.51	32.85
2	CSL	Australia	5123.71	4425.36	5093.01	4033.37	2846.27	15.78
3	Sigma Pharmaceuticals	Australia	3046.50	2942.16	2698.43	2592.35	2846.27	3.55
4	China National Accord Medicines Corporation	China	2859.52	2417.98	1929.75	1601.42	-	18.26
5	Ranbaxy Laboratories	India	2450.58	1994.00	1488.24	837.42	-	22.90
6	Yunnan Baiyao Group	China	2189.89	1809.97	1348.51	1176.68	1046.93	17.25
7	North China Pharmaceutical	China	1780.16	1960.16	1519.44	714.24	737.48	-9.18
8	Cipla	India	1617.22	1379.26	1178.00	955.19	852.33	22.42
9	Dr. Reddy's Laboratories	India	1571.97	1284.03	1158.30	1160.16	887.89	10.32
10	ResMed	Australia	1437.20	1302.70	929.84	725.31	645.51	35.64
11	Lupin	India	1395.48	1028.78	650.38	556.40	517.22	51.28
12	Guangzhou Pharmaceutical	China	1316.66	870.34	1327.56	1047.66	1062.72	-20.92
13	Sino Biopharmaceutical	China	1082.80	751.92	525.88	Sign up for the editor pick and get articles like this delivered right to your inbox. Name * Email * Country * Organisation * Contact Number * +Country Code-Phone Number(xxx-xxxxxxx) Submit Comments × Thank You Your comment has been submitted for approval. Please note that comments are moderated and are generally published if they are on-topic and not abusive. Comment × Your session has been expired. Please click here to Sign-in or Sign-up Log In To Comment   New User? Create Account Podcast   Editors Picks Rebooting Japan's biotech g... Cutting Clinical Costs with... Unleashing Innovative Wound... “Australia has long been a ... Premium Article Boosting Japan’s Biotech Ecosystem Advancing Japan’s Biotech Ecosystem Most read New Zealand to update clinical tria Singapore and Hong Kong sign MoU on Korea offers new breakthrough for h Biomanufacturing incubator opens at Survey Box Does Japan need to reboot its biotech growth engine? Yes No May be × Please select an option to participate in the poll. Vote   View poll results   More polls × You have successfully cast your vote. {{ optionDetail.option }}{{ optionDetail.percentage }}% {{ optionDetail.percentage }}% Complete More polls Subscribe to BioSpectrum Asia Subscribe Now! Enquiry Thanks for contacting us! We will get in touch with you shortly. Please fill the all fields. Name Email Enter a valid email address. Phone Message Send message Contact Us 1 North Bridge Road, #08-08 High Street Centre, Singapore 179094 Email : communications@biospectrumasia.com +65 90150305 Visit Our Digital Magazine BioSpectrum India NuFFooDS Spectrum Privacy Policy Sitemap © 2024 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer Web Interface Conceived and Powered By : SCI Knowledge Interlinks Have an Account? Login Create Account Forgot Password Login Email id Password Sign In Create Account City First Name Last Name Email ID Password Confirm Password Newsletter E-magazine Biospectrum Infomercial Bio Resource I accept the terms & condition & Privacy policy Sign Up Forgot Password Email id Submit Close × Subscribe To Our Newsletter Email ID I accept the terms & condition & Privacy policy SUBSCRIBE! Close